61 related articles for article (PubMed ID: 24447864)
21. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
[TBL] [Abstract][Full Text] [Related]
22. Quantification of p53 in epithelial ovarian cancer.
Geisler JP; Geisler HE; Wiemann MC; Givens SS; Zhou Z; Miller GA
Gynecol Oncol; 1997 Sep; 66(3):435-8. PubMed ID: 9299258
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
[TBL] [Abstract][Full Text] [Related]
24. Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer.
Yue X; Akahira J; Utsunomiya H; Miki Y; Takahashi N; Niikura H; Ito K; Sasano H; Okamura K; Yaegashi N
Pathol Int; 2010 May; 60(5):400-6. PubMed ID: 20518891
[TBL] [Abstract][Full Text] [Related]
25. The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study.
Riener EK; Arnold N; Kommoss F; Lauinger S; Pfisterer J
Gynecol Oncol; 2004 Oct; 95(1):89-94. PubMed ID: 15385115
[TBL] [Abstract][Full Text] [Related]
26. Inducible nitric oxide synthase expression in various laryngeal lesions in relation to carcinogenesis, angiogenesis, and patients' prognosis.
Shigyo H; Nonaka S; Katada A; Bandoh N; Ogino T; Katayama A; Takahara M; Hayashi T; Harabuchi Y
Acta Otolaryngol; 2007 Sep; 127(9):970-9. PubMed ID: 17712678
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients.
Schneider J; Jiménez E; Marenbach K; Romero H; Marx D; Meden H
Anticancer Res; 1999; 19(3A):2141-6. PubMed ID: 10470162
[TBL] [Abstract][Full Text] [Related]
28. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression].
Kieback DG; Press MF; McCamant SK; Atkinson EN; Möbus VJ; Runnebaum IB; Kreienberg R; Jones LA
Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):189-94. PubMed ID: 7789706
[TBL] [Abstract][Full Text] [Related]
30. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
Hetland TE; Hellesylt E; Flørenes VA; Tropé C; Davidson B; Kærn J
Hum Pathol; 2011 Jul; 42(7):1019-26. PubMed ID: 21315408
[TBL] [Abstract][Full Text] [Related]
31. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival.
Angelopoulou K; Rosen B; Stratis M; Yu H; Solomou M; Diamandis EP
Cancer; 1996 Nov; 78(10):2146-52. PubMed ID: 8918407
[TBL] [Abstract][Full Text] [Related]
32. Expression of cyclooxygenase-2 and its relation to histological grade, inducible nitric oxide synthase, matrix metalloproteinase-2, CD-34, Caspase-3, and CD8 in invasive ductal carcinoma of the breast.
Atik E; Akansu B; Bakaris S; Aban N
Saudi Med J; 2010 Feb; 31(2):130-4. PubMed ID: 20174726
[TBL] [Abstract][Full Text] [Related]
33. [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma].
Zhang MZ; Qiao YH; Suo ZH
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):848-52. PubMed ID: 19173831
[TBL] [Abstract][Full Text] [Related]
34. Association of clinicopathologic parameters with the expression of inducible nitric oxide synthase and vascular endothelial growth factor in mucoepidermoid carcinoma.
Ou Yang KX; Liang J; Huang ZQ
Oral Dis; 2011 Sep; 17(6):590-6. PubMed ID: 21624013
[TBL] [Abstract][Full Text] [Related]
35. E-cadherin as a prognostic marker in human serous carcinomas of the ovary: an immunohistochemical analysis.
Dian D; Brüning A; Mylonas I
Arch Gynecol Obstet; 2011 Aug; 284(2):437-43. PubMed ID: 20803206
[TBL] [Abstract][Full Text] [Related]
36. DNA adduct 8-hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma.
Karihtala P; Soini Y; Vaskivuo L; Bloigu R; Puistola U
Int J Gynecol Cancer; 2009 Aug; 19(6):1047-51. PubMed ID: 19820366
[TBL] [Abstract][Full Text] [Related]
37. Expression of trypsinogen-1, trypsinogen-2, and tumor-associated trypsin inhibitor in ovarian cancer: prognostic study on tissue and serum.
Paju A; Vartiainen J; Haglund C; Itkonen O; von Boguslawski K; Leminen A; Wahlström T; Stenman UH
Clin Cancer Res; 2004 Jul; 10(14):4761-8. PubMed ID: 15269150
[TBL] [Abstract][Full Text] [Related]
38. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
39. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
[TBL] [Abstract][Full Text] [Related]
40. Biologic prognostic factors in ovarian cancer: a review.
Framarino dei Malatesta ML; Veneziano M; Peppicelli M; Lanzi G; Marzetti L
Eur J Gynaecol Oncol; 1998; 19(2):123-5. PubMed ID: 9611049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
